Key Highlights

  • Net income for the quarter ended September 30, 2026 was USD 89.1 million, up from USD 66.7 million, driven by a USD 102.0 million unrealized gain on digital Assets versus USD 78.0 million a year earlier.
  • Revenue from consumer products fell 86.3% to USD 431,281 from USD 3.16 million, while digital asset Revenue from staking declined to USD 3.05 million from USD 6.08 million on lower Solana prices.
  • Income per share was USD 0.97 basic and USD 0.68 diluted, compared with USD 1.21 and USD 0.76, as basic weighted shares rose to 91.5 million from 55.3 million.
  • Stockholders' Equity was USD 49.2 million at September 30, 2026 against a Deficit of USD 53.8 million at June 30, 2026, while the company reported a Working Capital deficit of USD 11.4 million.

Fair Value Gains on Solana Produce the Profit

Upexi (NASDAQ:UPXI) filed its 10-Q for fiscal first quarter 2027, the three months ended September 30, 2026, on November 10, 2026. The company holds a treasury primarily in Solana (SOL) tokens, generating Yield through staking, and still sells consumer products wholesale and direct. Net Income was USD 89.1 million, but the filing shows it came from a USD 102.0 million unrealized gain on digital assets, which reflects changes in the Fair Value of its SOL holdings and is not cash. Net cash used in Operating Activities was USD 8.2 million. The company also recorded USD 1.5 million of realized losses on SOL sales and USD 0.2 million on converting staking revenue to dollars.

Legacy Product Business Shrinks as Costs Fall

Product revenue fell 86.3% because the company shifted away from legacy health, wellness and consumer lines and exited certain Manufacturing and distribution operations, and management does not expect significant revenue increases from these sources. Gross Margin on product revenue rose to about 79.4% from 69.7%. General and administrative expenses fell 23.8% to USD 7.1 million, with legal expenses up USD 1.9 million. Management expects legal expenses to stay elevated through March 31, 2027, then settle below USD 250,000 per quarter. Stock-based compensation fell to USD 3.9 million from USD 5.8 million, and other expenses rose to USD 3.2 million on Debt used to buy SOL.

Working Capital Deficit, Locked Tokens and Cheaper Debt

Working capital turned to a deficit of USD 11.4 million from a surplus of USD 45.6 million at June 30, but the filing says about USD 147.0 million of current liabilities are convertible notes whose principal can be settled on a noncash basis, so the deficit is not an equal cash need. Cash was about USD 6.4 million. In September 2026 the company negotiated its BitGo borrowing rate down to 7.5% from 11.5%, which it expects to cut annual interest by about USD 2.3 million on USD 57.3 million outstanding. It held 714,833 locked SOL tokens, unlocking through June 2028, which cannot be sold on normal exchanges. Management said it expects sufficient working capital for the next twelve months.

Where Things Stand

The profit came from a mark-to-market gain, not from operations. Upexi (NASDAQ:UPXI) earned USD 89.1 million because its Solana holdings were revalued upward by USD 102.0 million, while product revenue fell 86.3% and Operating Cash Flow was negative USD 8.2 million. That gain can reverse if SOL prices fall, and the filing itself says digital asset revenue will fluctuate with token prices and staking rates. The filing's wording on lower SOL prices versus a large fair value gain is not fully reconciled in the extract. Next markers are legal costs through March 2027, the lower BitGo interest burden and unlocking of the locked tokens.